Cargando…
Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells
Mitochondrial outer membrane permeabilization (MOMP), a key step in the intrinsic apoptotic pathway, is incompletely understood. Current models emphasize the role of BH3-only BCL2 family members in BAX and BAK activation. Here we demonstrate concentration-dependent BAK autoactivation under cell-free...
Autores principales: | Dai, Haiming, Ding, Husheng, Meng, X. Wei, Peterson, Kevin L., Schneider, Paula A., Karp, Judith E., Kaufmann, Scott H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617978/ https://www.ncbi.nlm.nih.gov/pubmed/26494789 http://dx.doi.org/10.1101/gad.267997.115 |
Ejemplares similares
-
Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization
por: Dai, Haiming, et al.
Publicado: (2011) -
Bak Conformational Changes Induced by Ligand Binding: Insight into BH3 Domain Binding and Bak Homo-Oligomerization
por: Pang, Yuan-Ping, et al.
Publicado: (2012) -
Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
por: Liu, Dongyan, et al.
Publicado: (2021) -
Correction: Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
por: Liu, Dongyan, et al.
Publicado: (2021) -
Risk of Lymphohematopoietic Malignancies in Uranium Miners
por: Möhner, Matthias
Publicado: (2007)